|Articles|November 17, 0001
Epilepsy drug linked to severe myopia, glaucoma
Washington, DC-Ortho-McNeil Pharmaceuticals is warning healthcareprofessionals that the epilepsy drug Topamax (topiramate) has been linkedto cases of severe myopia and secondary angle-closure glaucoma.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Research supports that iron dysregulation may drive AMD
2
UPDATE: STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
3
ONL Therapeutics randomizes first patient in phase 2 GALAXY trial evaluating xelafaslatide
4
Advancements in femtosecond laser technology benefit surgeons and patients
5













































.png)


